| Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas A Younes, NL Bartlett, JP Leonard, DA Kennedy, CM Lynch, EL Sievers, ... New England journal of medicine 363 (19), 1812-1821, 2010 | 1625 | 2010 |
| Cutaneous Lymphoma International Consortium study of outcome in advanced stages of mycosis fungoides and Sézary syndrome: effect of specific prognostic markers on survival and … JJ Scarisbrick, HM Prince, MH Vermeer, P Quaglino, S Horwitz, P Porcu, ... Journal of Clinical Oncology 33 (32), 3766-3773, 2015 | 432 | 2015 |
| Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis M Duvic, MT Tetzlaff, P Gangar, AL Clos, D Sui, R Talpur Journal of Clinical Oncology 33 (32), 3759-3765, 2015 | 330 | 2015 |
| Phase II investigator-initiated study of brentuximab vedotin in mycosis fungoides and Sézary syndrome with variable CD30 expression level: a multi-institution collaborative project YH Kim, M Tavallaee, U Sundram, KA Salva, GS Wood, S Li, S Rozati, ... Journal of Clinical Oncology 33 (32), 3750-3758, 2015 | 318 | 2015 |
| Genomic analysis of mycosis fungoides and Sézary syndrome identifies recurrent alterations in TNFR2 A Ungewickell, A Bhaduri, E Rios, J Reuter, CS Lee, A Mah, A Zehnder, ... Nature genetics 47 (9), 1056-1060, 2015 | 283 | 2015 |
| Low-dose total skin electron beam therapy as an effective modality to reduce disease burden in patients with mycosis fungoides: results of a pooled analysis from 3 phase-II … RT Hoppe, C Harrison, M Tavallaee, S Bashey, U Sundram, S Li, L Million, ... Journal of the American Academy of Dermatology 72 (2), 286-292, 2015 | 200 | 2015 |
| The prevalence of menstrual pain and associated risk factors among Iranian women M Tavallaee, MR Joffres, SJ Corber, M Bayanzadeh, M Mahmoudi Rad Journal of Obstetrics and Gynaecology Research 37 (5), 442-451, 2011 | 188 | 2011 |
| The epidemiology of Candida species associated with vulvovaginal candidiasis in an Iranian patient population M Mahmoudi Rad, S Zafarghandi, B Abbasabadi, M Tavallaee European Journal of Obstetrics & Gynecology and Reproductive Biology 155 (2 …, 2011 | 151 | 2011 |
| Identification of Candida species associated with vulvovaginal candidiasis by multiplex PCR MY Mahmoudi Rad, Zafarghandi ASh, Amel Zabihi M, Tavallaee M Infectious Diseases in Obstetrics & Gynecology, 2012 | 127* | 2012 |
| Useful parameters for distinguishing subcutaneous panniculitis-like T-cell lymphoma from lupus erythematosus panniculitis RE LeBlanc, M Tavallaee, YH Kim, J Kim The American journal of surgical pathology 40 (6), 745-754, 2016 | 88 | 2016 |
| The Iranian Population is Graying: Are we ready? S Kiani, M Bayanzadeh, M Tavallaee, RS Hogg Archives of Iranian Medicine 13 (4), 333, 2010 | 87 | 2010 |
| Obesity distribution and reproductive hormone levels in women: a report from the NHLBI-sponsored WISE Study MB Olson, LJ Shaw, EE Kaizar, SF Kelsey, V Bittner, SE Reis, K Smith, ... Journal of women's health 15 (7), 836-842, 2006 | 39 | 2006 |
| Characterization of the peripheral neuropathy associated with brentuximab vedotin treatment of Mycosis Fungoides and Sézary Syndrome ZA Corbin, A Nguyen-Lin, S Li, Z Rahbar, M Tavallaee, H Vogel, KA Salva, ... Journal of Neuro-oncology 132, 439-446, 2017 | 37 | 2017 |
| Drug-use patterns in an intensive care unit of a hospital in Iran: An observational prospective study M Tavallaee, F Fahimi, S Kiani International Journal of Pharmacy Practice 18 (6), 370-376, 2010 | 34 | 2010 |
| Paediatric primary cutaneous marginal zone B‐cell lymphoma: does it differ from its adult counterpart? I Amitay‐Laish, M Tavallaee, J Kim, RT Hoppe, L Million, M Feinmesser, ... British Journal of Dermatology 176 (4), 1010-1020, 2017 | 32 | 2017 |
| Fixed drug eruption resulting from fluconazole use: a case report M Tavallaee, MM Rad Journal of Medical Case Reports 3, 1-4, 2009 | 28 | 2009 |
| Variability in the expression of immunohistochemical markers: implications for biomarker interpretation in cutaneous T-cell lymphoma Z Rahbar, S Li, M Tavallaee, RA Novoa, J Kim, YH Kim The Journal of investigative dermatology 138 (5), 1204-1206, 2018 | 19 | 2018 |
| CD30 as a target for the treatment of cutaneous T-Cell lymphoma HM Prince Journal of Clinical Oncology 33 (32), 3691-3696, 2015 | 11 | 2015 |
| Phase II investigator-initiated study of brentuximab vedotin in mycosis fungoides or sezary syndrome: final results show significant clinical activity and suggest correlation … YH Kim, M Tavallaee, S Rozati, U Sundram, K Salva, GS Wood, S Li, ... Blood 124 (21), 804, 2014 | 9 | 2014 |
| Can we accurately diagnose endometriosis without a diagnostic laparoscopy? C Nezhat, S Agarwal, DA Lee, M Tavallaee Journal of the Turkish German Gynecological Association 23 (2), 117, 2022 | 7 | 2022 |
Mahnaz Mahmoudi RadAssociate professor of Medical Mycology, Skin Research Center, Shahid Beheshti University of Medical在 sbmu.ac.ir 的电子邮件经过验证
